Structures by: Anuradha N.
Total: 18
Chalcone
C16H13FOS
Acta Crystallographica Section E (2008) 64, 11 o2118-o2119
a=29.7846(9)Å b=5.7070(3)Å c=7.7071(4)Å
α=90° β=90.781(3)° γ=90°
Dihydropyrimidine
C14H16N2O2S
Acta Crystallographica Section E (2009) 65, 12 o3036
a=12.0415(2)Å b=6.22190(10)Å c=18.0192(3)Å
α=90° β=100.9010(10)° γ=90°
Dihydropyrimidine
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 12 o3068
a=7.2346(12)Å b=22.585(3)Å c=8.0941(15)Å
α=90° β=106.177(17)° γ=90°
Dihydropyrazine
C23H20N2
Acta Crystallographica Section E (2009) 65, 3 o546
a=10.4406(10)Å b=10.5753(7)Å c=11.0810(13)Å
α=93.439(8)° β=114.161(10)° γ=118.343(9)°
Dihydropyrimidine-2(1H)-thione
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 3 o564-o565
a=7.2389(6)Å b=8.2304(7)Å c=12.9038(11)Å
α=73.366(7)° β=89.373(7)° γ=72.613(7)°
Dihydropyrimidinone
C14H16N2O3
Acta Crystallographica Section E (2009) 65, 1 o23
a=23.7948(12)Å b=7.9905(3)Å c=14.4757(7)Å
α=90° β=108.305(5)° γ=90°
Pyrazoline
C16H13Cl2FN2OS
Acta Crystallographica Section E (2008) 64, 11 o2160
a=7.2240(5)Å b=8.8642(4)Å c=14.0518(9)Å
α=100.794(5)° β=103.307(6)° γ=101.003(5)°
4-[5-Methyl-4-(morpholin-4-ylcarbonyl)-1<i>H</i>-1,2,3-triazol-1-yl]- 8-(trifluoromethyl)quinoline
C18H16F3N5O2
Acta Crystallographica Section E (2008) 64, 12 o2375
a=9.2836(15)Å b=9.6164(11)Å c=9.9272(11)Å
α=92.082(9)° β=93.063(11)° γ=105.728(12)°
Dihydropyrimidinone
C13H13ClN2O2
Acta Crystallographica Section E (2008) 64, 12 o2474-o2475
a=14.5364(8)Å b=12.1587(5)Å c=7.0780(4)Å
α=90° β=90° γ=90°
Triphenylpyrazine
C22H16N2
Acta Crystallographica Section E (2009) 65, 1 o106
a=15.563(2)Å b=6.2005(9)Å c=16.845(3)Å
α=90° β=90° γ=90°
Cyclohex-2-enone
C21H19ClO3
Acta Crystallographica Section E (2009) 65, 1 o191
a=8.0115(3)Å b=11.3525(4)Å c=11.6386(4)Å
α=62.261(2)° β=77.975(2)° γ=75.297(2)°
Cyclohex-2-enone
C21H19BrO3
Acta Crystallographica Section E (2010) 66, 8 o1896
a=11.0138(2)Å b=13.8197(4)Å c=12.1477(3)Å
α=90° β=95.180(2)° γ=90°
Dihydropyrimidin-2(1H)-thione
C13H14N2OS
Acta Crystallographica Section E (2010) 66, 9 o2280
a=7.8849(10)Å b=7.2054(5)Å c=21.555(3)Å
α=90° β=94.401(12)° γ=90°
2,3-dihydropyrazine
C23H19ClN2
Acta Crystallographica Section E (2011) 67, 10 o2598
a=10.5675(8)Å b=19.7014(9)Å c=10.4207(7)Å
α=90° β=118.479(9)° γ=90°
2,3-dihydropyrazine
C24H22N2
Acta Crystallographica Section E (2012) 68, 11 o3084
a=8.1986(5)Å b=11.8211(6)Å c=19.6686(7)Å
α=90° β=93.638(4)° γ=90°
Pyrazine
C24H20N2
Acta Crystallographica Section E (2012) 68, 10 o3003
a=9.2327(9)Å b=9.8708(11)Å c=10.6787(14)Å
α=79.604(10)° β=70.351(11)° γ=87.848(8)°
Dihydropyrimidin-2(1H)-thione
C13H13FN2OS
Acta Crystallographica Section E (2012) 68, 9 o2625
a=7.1775(11)Å b=8.1099(13)Å c=12.490(2)Å
α=103.529(15)° β=91.933(14)° γ=106.971(14)°
Dihydropyrimidin-2(1H)-thione
C16H20N2OS
Acta Crystallographica Section E (2012) 68, 9 o2641
a=26.8413(5)Å b=9.5657(2)Å c=12.0764(2)Å
α=90° β=90.370(2)° γ=90°